Thomas Kazmirchuk on AI-Generated Peptide Targeting Platelet-type von Willebrand Disease
Thomas Kazmirchuk, Associate Research Fellow at Queen’s University, shared on LinkedIn:
”I am absolutely thrilled to share that my study on how we designed, screened, validated, and confirmed peptides with therapeutic and diagnostic utility in Platelet-type von Willebrand disease that was accepted in Blood Advances is now available online as a first edition!
This work brought together many disciplines from biochemistry, AI, hematology, and others to address a critical need in PT VWD and bleeding disorders as a whole.
Thank you to Ashkan Golshani, Dr. Maha Othman MD MSc PhD for your endless support during this project.
I would also like to thank our collaborators in Dr. Gresele’s lab at the University of Perugia for their assistance.
And thank you to the expert reviewers and of course the editorial staff at the American Society of Hematology’s Blood Advances.
The future is bright for hematology, medicine, and those with bleeding disorders.”
Read the full paper here.
Article: Developing an AI-Generated Peptide Targeting Platelet-type von Willebrand Disease
Authors: Thomas David Daniel Kazmirchuk, Jiashu Wang, Loredana Bury, Emanuela Falcinelli, Calvin Bradbury-Jost, Anastasiia Koziar, Mustafa Al-gafari, Sarah Takallou, William G Willmore, Frank Dehne, Paolo Gresele, Maha Othman, Ashkan Golshani
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Nov 15, 2025, 12:24Thomas Reiser: Can AI Keep Up with Thrombosis Specialists?
-
Nov 15, 2025, 12:13Michael Makris on Immediate Suspension of Use of Plasma Derived FIX Concentrates in Punjab
-
Nov 15, 2025, 09:32Tushar Pandey: Hounoured to Be Part of Hematocon 2025
-
Nov 15, 2025, 09:11Lisa Murphy invites You to Join Her at Stroke Foundation’s Run4Stroke Marathon
-
Nov 15, 2025, 08:56Ahmed Bennis on Potential Use of P2Y12 Inhibitors as Safer Alternative in Monotherapy
-
Nov 15, 2025, 08:39Marika Nöjd: Donating Blood is An Easy Way to Do Good!
-
Nov 15, 2025, 08:19Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
-
Nov 15, 2025, 07:14Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
-
Nov 15, 2025, 07:03Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action